Efficacy and quality of life changes in switching traditional rapid acting insulin to ultra rapid Lispro in patients with type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000048528
- Lead Sponsor
- Minami Osaka Hospital Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients allergic to insulin lispro 2) Patients who cannot administer ultra rapid Lispro within 2 minutes before meals and within 20 minutes from the start of meals when necessary.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Time in range from Freestyle Libre Pro data and ITR-QOL score by switching traditional rapid acting insulin to ultra rapid Lispro.
- Secondary Outcome Measures
Name Time Method